市場調查報告書
商品編碼
1056156

獸醫參考實驗室市場:成長、趨勢、COVID-19影響、預測 (2022∼2027年)

Veterinary Reference Laboratory Market- Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 106 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

獸醫參考實驗室的市場在預測期間內,預計以8.94%的年複合成長率成長。

經濟已開發國家的伴侶動物及寵物的飼養數量增加,加速該市場的成長。根據Pet Food Manufacturers Association,估計在英國2021年59%的家庭的1,700萬戶養寵物。這成為在預測期間內的市場成長的原動力。同時,迅速檢驗和POC (照護現場) 服務用的可攜式設備的成本,及寵物照護成本增加,有給市場成長帶來一定的負面影響的可能性。

本報告提供全球獸醫參考實驗室市場調查,市場概要,市場影響因素的分析,市場規模、預測,各服務類型、用途、動物、地區/主要國家的明細,主要企業的簡介,未來展望等彙整資料。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 推動市場要素
  • 阻礙市場要素

第5章 市場分類

  • 各服務形式
    • 臨床化學檢驗
    • 血液檢驗
    • 免疫診斷
    • 分子診斷
    • 其他
  • 各用途
    • 病理
    • 細菌
    • 病毒
    • 寄生蟲
    • 其他
  • 各動物
    • 寵物
    • 家畜
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 企業簡介、競爭情形

  • 企業簡介
    • IDEXX Laboratories, Inc.
    • GD Animal Health
    • Greencross Limited
    • Heska Corporation
    • Zoetis Inc.
    • Mars Inc.
    • Neogen Corporation
    • Boehringer Ingelheim International GmbH
    • Veterinary Diagnostic Laboratory-University of Minnesota

第7章 市場機會、未來趨勢

目錄
Product Code: 72454

As per the analysis, the veterinary reference laboratory market is expected to gain market growth with a CAGR of 8.94% in the forecast period of 2021 to 2026. The number of pet adoptions will act as a major market driver for the growth of the veterinary reference laboratory market.

The worldwide lockdown due to the covid-19 outbreak had suspended trade affairs with other countries and implemented travel restrictions from one to another. This has affected the export and import of veterinary supplies like medicines and diagnostics, which has led to a decline in sales of many products and a downfall in many segments. Supply disruption and medicine shortages of veterinary medicines were also observed in several countries due to the temporary lockdowns of manufacturing sites, export bans, and limiting the workforce.

According to the article Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2): A Perspective Through the Lens of the Veterinary Diagnostic Laboratory, published in September 2020, the infection rate in pet animals was low during the COVID-19 outbreak. In "Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy" a study from Italy, no viral RNA was detected in nasopharyngeal, nasal and/or rectal swabs from 839 pet dogs and cats, including 76 animals with clinical signs of respiratory disease. Among the tested animals, 14% were from households with COVID-19. Also, serum neutralizing antibodies was detected in 3-4% of animals, although the maximum proportion of serologically positive dogs were from COVID-19 vs. non-COVID-19 households. These studies show that during the period 2020-2021 the demand for the veterinary reference laboratory has been increased due to more pet healthcare attention.

The increase in the companion/pet animal population in developed economic countries is driving the market to grow faster. According to Pet Food Manufacturers Association, United Kingdom in the year 2021 it is estimated that 17 million (59% of total households) households' own pets. Hence, this is expected to drive the market growth during the forecast period. Amid all the benefits and driving factors for the growth of the veterinary reference laboratory market, the cost of the rapid tests, portable instruments for point-of-care (POC) services and increasing pet care costs might adversely affect the market growth to a certain extent.

Key Market Trends

Molecular Diagnostics segment by service type is likely to witness the highest growth in the forecast period

The high growth in molecular diagnostics segment is rising due to the rising preference of veterinarians and laboratory technicians for a variety of advanced clinical diagnostic services by the pet owners. These molecular diagnostics segment offers testing of a verity of animal pathogens using molecular based methods. These methods include conventional, real-time, and quantitative PCR. Genetic sequencing is also available for a few pathogens. Among all the tests PCR and Rapid tests are in high demand since 2020, after the covid-19 outbreak.

While Covid-19 has started, various research has been conducted to find out how covid-19 is affecting animals. For that PCR tests were conducted. This trend increased the demand for the PCR panels. Because in this case, pet owners are most likely to start testing their pets for the absence of these diseases, increasing the demand for PCR panels for virus testing and this will create many opportunities for new chemical and molecular diagnostics panels in the industry.

A major market player in the studied market, IDEXX Laboratories, Inc. (USA) has introduced a PCR panel for animals, and it has tested more than 6000 samples so far. There have been regulations for it and certain criteria also, including developing symptoms in pets after the owners have been tested positive. That means one can order the test IDEXX, only when all the other tests come negative for the animal. These tests include upper respiratory disease PCR panels, comprehensive respiratory disease PCR panels, influenza virus PCR panels, and others. Also, the growing demand for inexpensive, convenient, and fast diagnostic test equipment is expected to boost the global veterinary reference laboratory market in this segment.

North America is expected to have a significant and highest share and expected to hold its share in the forecast period as well.

As per geography study, North America dominated the global industry in 2016 and after. The United States. market for the studied market is growing consistently since then. High prevalence of livestock animals and zoonotic diseases coupled with the rising pet ownership affecting the industry growth in this region positively. After the 2020 Covid-19 pandemic, the region has more demand for the Veterinary Reference Laboratory market. The United States and other states in the region have taken extraordinary steps to cope with the pandemic situation for improved human healthcare was tremendous.

In contrast to the decline in sales, as per the reports of the Society for the Prevention of Cruelty to Animals, Los Angeles, the rate of adoption was doubled in June 2020. The report suggests daily adoptions of pet animals were about 10 to 13 per day. The rising adoption of pets may drive the growth of the veterinary healthcare management market in the longer-term process in the forecast period.

The market players are taking new strategies to take the market to its projected horizon, and some are already seeing the growth. The 3rd quarter annual reports of IDEXX Laboratories, Inc. states that, the positive global trends in companion animal healthcare continue to support rapid growth for annual growth rate of diagnostic products and services across regions. Also, according to the annual report, in the United States same-store clinical visit has growth at veterinary practices such as non-wellness visits and wellness visits. These clinical visits gained more growth than the prior year period clinical visit. This growth of the veterinary market includes benefits from the delayed veterinary visits during the COVID-19 pandemic. On a two-year average annual basis, United States clinical visit growth remained above pre-pandemic levels.

These major collaborations and partnerships boosted the demand for the market during 2020-2021 and contributed the market growth during the current year. But the escalation of pet approval, improving awareness about animal health, and increase in animal health expenses in the developed countries in North America are the drivers to boost the growth of the veterinary reference laboratory market. Due to these collaborations the veterinary reference laboratories are getting equipped with the most recent technological advancements and increasing the veterinary reference laboratory market demand.

According to American Pet Products Association's (APPA) National Pet Owners Survey (2021-2022) 70% of households in the United States reported as pet owners. North American Pet Health Insurance Association (NAPHIA), State of the Industry Report for 2021 show the total number of pets insured in 2020 reached 3.1 million, up from 2.5 million in 2019. This report also states that dogs continue to be the major insured pets with 82.9% and cats for 17.1%. Thus, with the above-mentioned factors the market is expected to fuel the market growth in this region.

Competitive Landscape

The key market players have undertaken crucial business strategies like regional expansion strategies, mergers and acquisitions, and collaborative research initiatives, to gain a higher competitive edge. Some of the key players in the market studied are IDEXX Laboratories, Inc. (USA), GD Animal Health (Netherlands), Greencross Limited (Australia), Heska Corporation (Colorado), Animal and Plant Health Agency (U.K.), Randox Laboratories Ltd. (India), Zoetis Inc. (USA), VCA Inc. (USA), Neogen Corporation (USA), Boehringer Ingelheim International GmbH.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increase in Companion animal/Pet Adoption
    • 4.2.2 Increasing Demand for Pet Insurance
    • 4.2.3 Growing Demand for Animal Healthcare Expenditure
    • 4.2.4 Growing Demand for Animal Based Food Products
    • 4.2.5 Grown up Deamands for PCR testing, Rapid testing and other portable instruments
  • 4.3 Market Restraints
    • 4.3.1 Rising demand for portable devices for point-of-care (POC) services
    • 4.3.2 High in Pet Care Cost

5 MARKET SEGMENTATION

  • 5.1 By Service Type
    • 5.1.1 Clinical Chemistry
    • 5.1.2 Haematology
    • 5.1.3 Immunodiagnostics
    • 5.1.4 Moecular Diagnostics
    • 5.1.5 Others
  • 5.2 By Application
    • 5.2.1 Pathology
    • 5.2.2 Bacteriology
    • 5.2.3 Virology
    • 5.2.4 Parasitology
    • 5.2.5 Others
  • 5.3 By Animal
    • 5.3.1 Companion Animal
    • 5.3.2 Livestock Animal
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 United Kingdom
      • 5.4.2.2 France
      • 5.4.2.3 Germany
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 India
      • 5.4.3.2 China
      • 5.4.3.3 Japan
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPANY PROFILES AND COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 IDEXX Laboratories, Inc.
    • 6.1.2 GD Animal Health
    • 6.1.3 Greencross Limited
    • 6.1.4 Heska Corporation
    • 6.1.5 Zoetis Inc.
    • 6.1.6 Mars Inc.
    • 6.1.7 Neogen Corporation
    • 6.1.8 Boehringer Ingelheim International GmbH
    • 6.1.9 Veterinary Diagnostic Laboratory-University of Minnesota

7 MARKET OPPORTUNITIES AND FUTURE TRENDS